During the past decade, The Eye Care Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Eye Care Group" #1 collaborator was "Icahn School of Medicine at Mount Sinai" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "University of Iowa" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "The Eye Care Group" are "Idiopathic Intracranial Hypertension" (1 trials) and "Nonarteritic Anterior Ischemic Optic Neuropathy" (1 trials). Many other conditions were trialed in "The Eye Care Group" in a lesser frequency.

Most popular intervention types in "The Eye Care Group" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acetazolamide" (1 trials), "Optic Nerve Sheath Fenestration" (1 trials), "Placebo Cohort A" (1 trials), "Placebo Cohort B" (1 trials) and "RPh201 Cohort A" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Eye Care Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "The Eye Care Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The Eye Care Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Eye Care Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".